- ABOUT ME
- AREAS OF FOCUS
- EDUCATION & LEADERSHIP
- LOCATIONS & HOSPITALS
- NEWS & PUBLICATIONS
Dr. Scott Brancato began his career as a chemical engineer but soon realized he wanted to apply his problem-solving and technical skills in a medical field with direct patient impact. He discovered the ideal blend of analytical thinking and personal care in cardiac electrophysiology, a specialty that focuses on complex heart rhythm disorders with treatments that can immediately transform patients’ quality of life.
In his cardiology practice, Dr. Brancato manages the full spectrum of heart rhythm conditions, including atrial fibrillation, supraventricular tachycardia, ventricular tachycardia, and bradycardia. He has performed more than 6,000 cardiac electrophysiology procedures, including over 2,000 atrial fibrillation ablations and more than 3,000 pacemaker and defibrillator implants. His background as a medical director and clinical research leader ensures patients receive the most current evidence-based treatments.
Dr. Brancato finds deep satisfaction in helping patients reclaim their vitality after years of living with fatigue, palpitations, and shortness of breath. He partners closely with patients to help them understand their conditions, empowering them to make confident treatment decisions. Nothing rewards him more than seeing patients after successful procedures, finally feeling like themselves again.
For Dr. Brancato, the balance between natural beauty, strong community values, and a vibrant culture makes Portland ideal for raising a family and practicing medicine. He spends most of his free time outdoors with his family exploring the Pacific Northwest and finding new trails, parks, and local spots to enjoy. Staying active year-round through skiing, running, and cycling is important to Dr. Brancato for balance and well-being as well as fitness.
Other Activities
Fellow, Heart Rhythm Society
Chair, Accreditation and Assessment Committee, Heart Rhythm Society
Areas of Focus
Cardiac Electrophysiology
Arrhythmias
Atrial Fibrillation
Ventricular Tachycardia
Ablation
Pacemakers
Defibrillators
EDUCATION & TRAINING
Fellowship, Clinical Cardiac Electrophysiology, Harvard Medical School, 2012
Fellowship, Cardiovascular Diseases, Alpert Medical School of Brown University, 2011
Residency, Internal Medicine, Alpert Medical School of Brown University, 2008
MD, Georgetown University School of Medicine, 2005
BS, Chemical Engineering, University of Virginia
BOARD CERTIFICATION
Clinical Cardiac Electrophysiology
Cardiovascular Diseases
Locations
Hospitals Served
- Legacy Meridian Park Medical Center
- Providence St. Vincent Medical Center
- Oregon Health & Science University
Publications
Hills M, Korjian S, Chi G, Natale A, Saxon L, Ferdinand K, Kwaku K, Brancato S, Baca-Motes K, Steinhubl S, Wessler J, Goldberg N, Asthana A, Shute K, Applebaum J, Doran K, Nikolovski J, Kaul S, Wentworth D, Damaraju C, DeFalco F, Tavakoli C, Patel M, Curtis A, Spertus J, Gibson C. Insights for direct-to-patient clinical trial recruitment strategies from the Heartline study. Circulation. 2024;150(Suppl_1):4143017. doi:10.1161/circ.150.suppl_1.4143017.
Knoepke CE, Wallace BC, Allen LA, Lewis CL, Gupta SK, Peterson PN, Kramer DB, Brancato SC, Varosy PD, Mandrola JM, Tzou WS, Matlock DD. Experiences implementing a suite of decision aids for implantable cardioverter defibrillators: qualitative insights from the DECIDE-ICD trial. Circ Cardiovasc Qual Outcomes. 2022;15(11):e009352. doi:10.1161/CIRCOUTCOMES.122.009352.
Brancato SC, Wang M, Spinelli KJ, Gandhavadi M, Worrall NK, Lehr EJ, DeBoard ZM, Fitton TP, Leiataua A, Piccini JP, Gluckman TJ. Temporal trends and predictors of surgical ablation for atrial fibrillation across a multistate healthcare system. Heart Rhythm O2. 2021 Dec 24;3(1):32-39. doi: 10.1016/j.hroo.2021.12.003. eCollection 2022 Feb.
Wallace BC, Allen LA, Knoepke CE, Glasgow RE, Lewis CL, Fairclough DL, Helmkamp LJ, Fitzgerald MD, Tzou WS, Kramer DB, Varosy PD, Gupta SK, Mandrola JM, Brancato SC, Peterson PN, Matlock DD. A multicenter trial of a shared DECision Support Intervention for Patients offered implantable Cardioverter-DEfibrillators: DECIDE-ICD rationale, design, Medicare changes, and pilot data. Am Heart J. 2020 Aug;226:161-173.
Zghaib T, Ipek EG, Hansford R, Ashikaga H, Berger RD, Marine JE, Spragg DD, Tandri H, Zimmerman SL, Halperin H, Brancato S, Calkins H, Henrikson C, Nazarian S. Standard Ablation Versus Magnetic Resonance Imaging-Guided Ablation in the Treatment of Ventricular Tachycardia. Circ Arrhythm Electrophysiol. 2018 Jan;11(1).